Search hospitals > Illinois > Springfield
Memorial Medical Center
Claim this profileSpringfield, Illinois 62702
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Stomach Cancer
Conducts research for Lung Cancer
Conducts research for Relapse
435 reported clinical trials
4 medical researchers
Summary
Memorial Medical Center is a medical facility located in Springfield, Illinois. This center is recognized for care of Skin Cancer, Breast Cancer, Stomach Cancer, Lung Cancer, Relapse and other specialties. Memorial Medical Center is involved with conducting 435 clinical trials across 575 conditions. There are 4 research doctors associated with this hospital, such as Bryan A. Faller, James L. Wade, Stephen Hazelrigg, MD, and Tony DeMartini, MD.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Bryan A. FallerCrossroads Cancer Center6 years of reported clinical research
Expert in Skin Cancer
Expert in Lung Cancer
239 reported clinical trials
296 drugs studied
James L. WadeDecatur Memorial Hospital4 years of reported clinical research
Studies Relapse
Studies Breast Cancer
11 reported clinical trials
20 drugs studied
Stephen Hazelrigg, MDMemorial Medical Center7 years of reported clinical research
Studies Heart Failure
Studies Ventricular Dysfunction
2 reported clinical trials
2 drugs studied
Tony DeMartini, MDMemorial Medical Center4 years of reported clinical research
Studies Cardiomyopathy
Studies Coronary Heart Disease
1 reported clinical trial
1 drug studied
Clinical Trials running at Memorial Medical Center
Skin Cancer
Breast Cancer
Lung Cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Breast cancer
Stomach Cancer
Multiple Myeloma
Pancreatic Cancer
Esophageal Adenocarcinoma
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Focused Radiation vs Systemic Therapy
for Kidney Cancer
This phase III trial compares the effect of stero-ablative radiotherapy (SAbR) followed by standard of care systemic therapy, to standard of care systemic therapy alone, in patients with kidney cancer that has spread from where it first started (primary site) to a limited (2-5) number of places in the body (metastatic). Study doctors want to find out if this approach is better or worse than the usual approach for metastatic kidney cancer. The usual approach is defined as the care most people get for metastatic kidney cancer which includes systemic therapy such as immunotherapy (given through the veins) and/or small molecular inhibitor (tablets taken by mouth). Radiotherapy uses high energy x-rays to kill cancer cells and shrink tumors. SAbR uses special equipment to position a patient and deliver radiation to tumors with high precision. Giving SAbR prior to systemic therapy may kill more tumor cells than the usual approach, which is systemic therapy alone.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Memorial Medical Center?
Memorial Medical Center is a medical facility located in Springfield, Illinois. This center is recognized for care of Skin Cancer, Breast Cancer, Stomach Cancer, Lung Cancer, Relapse and other specialties. Memorial Medical Center is involved with conducting 435 clinical trials across 575 conditions. There are 4 research doctors associated with this hospital, such as Bryan A. Faller, James L. Wade, Stephen Hazelrigg, MD, and Tony DeMartini, MD.
Where is Memorial Medical Center located?
**Memorial Medical Center**
- **Address:** 701 N. First St., Springfield, IL 62781
- **Amenities:** Elevators, food services, free parking, patient waiting rooms, wheelchair accessibility.
Who should I call to ask about financial aid or insurance network?
**Memorial Medical Center Contact Information**
**Financial Assistance:**
- Patient Financial Services Department: 954-276-5501
- Eligibility Department: 954-276-5760
- Visit Admitting/registration areas in the main lobby of any acute care facility
- Eligibility Office Hours: Monday-Friday, 8 am to 4:30 pm
**Insurance:**
- For coverage-related questions, contact your insurance provider directly.
**Additional Assistance:**
- Customer Service Department: 989-720-2000
What insurance does Memorial Medical Center accept?
Memorial Medical Center accepts a variety of insurance plans such as Blue Cross Blue Shield, Cigna, Humana, Medicare, NM Medicaid, Presbyterian, TriCare, Western Sky, and United Health Care. MemorialCare Medical Group and Urgent Care accept major HMO, PPO, EPO health plans, Medicare, private indemnity, and supplemental insurance plans. Memorial Health and Memorial Healthcare System also support a broad spectrum of insurance options, including Commercial, ACA/Exchange, Medicare, Medicare Advantage, Medicaid, and provide a self-insured plan for businesses.
What awards or recognition has Memorial Medical Center received?
Memorial Medical Center, located in Springfield, Illinois, has been nationally recognized for its excellence in stroke care, earning the prestigious American Hospital Association's top national award for quality and safety. It holds accreditation from The Joint Commission and boasts Magnet recognition for nursing excellence. The hospital has a rich history of healthcare innovation since its founding in 1897.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.